FEMASYS
Biotechnology company with a recent SEC Form D offering.
Biotechnology company headquartered in SUWANEE, GEORGIA. Filed SEC Form D on 20260820 for a $30.0M Regulation D offering.
Biotech
📍 SUWANEE, GEORGIA
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is FEMASYS going public?
No. FEMASYS is private and has not filed to go public. There is no S-1 on file.
What is FEMASYS' valuation in 2026?
No confirmed valuation is on record for FEMASYS. The roster shows funding and investors where they are public; it does not estimate a mark.
Has FEMASYS filed an S-1?
No public S-1 is on file for FEMASYS.
How much has FEMASYS raised?
FEMASYS has raised $30M in total, most recently a Form D filing of $30M in 20260820.
Is FEMASYS publicly traded — can you buy FEMASYS stock?
No. FEMASYS is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for FEMASYS on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Growth
Filed SEC Form D on 20260820 for $30.0M Regulation D offering
Last Round
Form D filing — $30M (20260820)
Fundraising Status
Form D filing · $30M
privateTotal raised $30M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $30M | 20260820 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
Registered trials
6
2 active · 1 recruiting
Focus areas
Contraception
Fallopian Tube Patency Tests · Infertility
Latest trial start
2023-10-31
Talent Signal
No public careers page or job board could be found for FEMASYS as of 2026-09-23. That itself is a datapoint: no open external hiring surface.
Key Executive Moves
INJohn CanningCOO · 2026-09-04
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Checked the company site and major hosted job boards. Re-checked monthly.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.